Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Adam Mussell is active.

Publication


Featured researches published by Adam Mussell.


American Journal of Transplantation | 2014

Mortality and Cardiovascular Disease Among Older Live Kidney Donors

Peter P. Reese; Roy D. Bloom; Harold I. Feldman; Paul R. Rosenbaum; Wei Wang; Philip A. Saynisch; N. M Tarsi; Nabanita Mukherjee; Amit X. Garg; Adam Mussell; Justine Shults; Orit Even-Shoshan; Raymond R. Townsend; Jeffrey H. Silber

Over the past two decades, live kidney donation by older individuals (≥55 years) has become more common. Given the strong associations of older age with cardiovascular disease (CVD), nephrectomy could make older donors vulnerable to death and cardiovascular events. We performed a cohort study among older live kidney donors who were matched to healthy older individuals in the Health and Retirement Study. The primary outcome was mortality ascertained through national death registries. Secondary outcomes ascertained among pairs with Medicare coverage included death or CVD ascertained through Medicare claims data. During the period from 1996 to 2006, there were 5717 older donors in the United States. We matched 3368 donors 1:1 to older healthy nondonors. Among donors and matched pairs, the mean age was 59 years; 41% were male and 7% were black race. In median follow‐up of 7.8 years, mortality was not different between donors and matched pairs (p = 0.21). Among donors with Medicare, the combined outcome of death/CVD (p = 0.70) was also not different between donors and nondonors. In summary, carefully selected older kidney donors do not face a higher risk of death or CVD. These findings should be provided to older individuals considering live kidney donation.


American Journal of Transplantation | 2013

Early Rehospitalization After Kidney Transplantation: Assessing Preventability and Prognosis

Meera N. Harhay; Eugene Lin; A. Pai; Michael O. Harhay; A. Huverserian; Adam Mussell; Peter L. Abt; Matthew H. Levine; Roy D. Bloom; Judy A. Shea; Andrea B. Troxel; Peter P. Reese

Early rehospitalization after kidney transplantation (KT) is common and may predict future adverse outcomes. Previous studies using claims data have been limited in identifying preventable rehospitalizations. We assembled a cohort of 753 adults at our institution undergoing KT from January 1, 2003 to December 31, 2007. Two physicians independently reviewed medical records of 237 patients (32%) with early rehospitalization and identified (1) primary reason for and (2) preventability of rehospitalization. Mortality and graft failure were ascertained through linkage to the Scientific Registry of Transplant Recipients. Leading reasons for rehospitalization included surgical complications (15%), rejection (14%), volume shifts (11%) and systemic and surgical wound infections (11% and 2.5%). Reviewer agreement on primary reason (85% of cases) was strong (kappa = 0.78). Only 19 rehospitalizations (8%) met preventability criteria. Using logistic regression, weekend discharge (odds ratio [OR] 1.59, p = 0.01), waitlist time (OR 1.10, p = 0.04) and longer initial length of stay (OR 1.42, p = 0.03) were associated with early rehospitalization. Using Cox regression, early rehospitalization was associated with mortality (hazard ratio [HR] 1.55; p = 0.03) but not graft loss (HR 1.33; p = 0.09). Early rehospitalization has diverse causes and presents challenges as a quality metric after KT. These results should be validated prospectively at multiple centers to identify vulnerable patients and modifiable processes‐of‐care.


Transplantation | 2014

Functional status and survival after kidney transplantation

Peter P. Reese; Roy D. Bloom; Justine Shults; Arwin Thomasson; Adam Mussell; Sylvia E. Rosas; Kirsten L. Johansen; Peter L. Abt; Matthew H. Levine; Arthur L. Caplan; Harold I. Feldman; Jason Karlawish

Background Older patients constitute a growing proportion of U.S. kidney transplant recipients and often have a high burden of comorbidities. A summary measure of health such as functional status might enable transplant professionals to better evaluate and counsel these patients about their prognosis after transplant. Methods We linked United Network for Organ Sharing registry data about posttransplantation survival with pretransplantation functional status data (physical function [PF] scale of the Medical Outcomes Study Short Form-36) among individuals undergoing kidney transplant from June 1, 2000 to May 31, 2006. We examined the relationship between survival and functional status with multivariable Cox regression, adjusted for age. Using logistic regression models for 3-year survival, we also estimated the reduction in deaths in the hypothetical scenario that recipients with poor functional status in this cohort experienced modest improvements in function. Results The cohort comprised 10,875 kidney transplant recipients with a mean age of 50 years; 14% were ≥65. Differences in 3-year mortality between highest and lowest PF groups ranged from 3% among recipients <35 years to 14% among recipients ≥65 years. In multivariable Cox regression, worse PF was associated with higher mortality (hazard ratio, 1.66 for lowest vs. highest PF quartiles; P<0.001). Interactions between PF and age were nonsignificant. We estimated that 11% fewer deaths would occur if kidney transplant recipients with the lowest functional status experienced modest improvements in function. Conclusions Across a wide age range, functional status was an independent predictor of posttransplantation survival. Functional status assessment may be a useful tool with which to counsel patients about posttransplantation outcomes.


American Journal of Transplantation | 2015

Selecting appropriate controls for kidney donors--reply.

Peter P. Reese; Roy D. Bloom; Harold I. Feldman; Amit X. Garg; Adam Mussell; Justine Shults; Jeffrey H. Silber

It is not possible to randomize an individual to become a living kidney donor. Therefore, we agree with Mjøen and Holdaas that it is necessary to examine the comparability of the baseline characteristics of the donor and nondonor groups in any study of living donor outcomes (1). We stand by the conclusion of our manuscript, which reads: ‘‘In the context of careful medical evaluation and selection, older donors should expect similar medium-term survival and risk of CVD compared to healthy members of the general population’’ (2, p. 1859).


PLOS ONE | 2016

Measures of Global Health Status on Dialysis Signal Early Rehospitalization Risk after Kidney Transplantation

Meera N. Harhay; Alexander S. Hill; Wei Wang; Orit Even-Shoshan; Adam Mussell; Roy D. Bloom; Harold I. Feldman; Jason Karlawish; Jeffrey H. Silber; Peter P. Reese

Background Early rehospitalization (<30 days) after discharge from kidney transplantation (KT) is associated with poor outcomes. We explored summary metrics of pre-transplant health status that may improve the identification of KT recipients at risk for early rehospitalization and mortality after transplant. Materials and Methods We performed a retrospective cohort study of 8,870 adult (≥ 18 years) patients on hemodialysis who received KT between 2000 and 2010 at United States transplant centers. We linked Medicare data to United Network for Organ Sharing data and data from a national dialysis provider to examine pre-KT (1) Elixhauser Comorbidity Index, (2) physical function (PF) measured by the Short Form 36 Health Survey, and (3) the number of hospitalizations during the 12 months before KT as potential predictors of early rehospitalization after KT. We also explored whether these metrics are confounders of the known association between early rehospitalization and post-transplant mortality. Results The median age was 52 years (interquartile range [IQR] 41, 60) and 63% were male. 29% were rehospitalized in <30 days, and 20% died during a median follow-up time of five years (IQR 3.6–6.5). In a multivariable logistic model, kidney recipients with more pre-KT Elixhauser comorbidities (adjusted odds ratio [aOR] 1.09 per comorbidity, 95% Confidence Interval [CI] 1.07–1.11), the poorest pre-KT PF (aOR 1.24, 95% CI 1.08–1.43), or >1 pre-KT hospitalizations (aOR 1.32, 95% CI 1.17–1.49) were more likely to be rehospitalized. All three health status metrics and early rehospitalization were independently associated with post-KT mortality in a multivariable Cox model (adjusted hazard ratio for rehospitalization: 1.41, 95% CI 1.28–1.56) Conclusions Pre-transplant metrics of health status, measured by dialysis providers or administrative data, are independently associated with early rehospitalization and mortality risk after KT. Transplant providers may consider utilizing metrics of pre-KT global health status as early signals of vulnerability when transitioning care after KT.


Clinical Transplantation | 2018

Outcomes for individuals turned down for living kidney donation: XXXX

Peter P. Reese; Matthew B. Allen; Caroline Carney; Daniel Leidy; Simona Levsky; Ruchita Pendse; Adam Mussell; Francisca Bermudez; Shimrit Keddem; Carrie Thiessen; James R. Rodrigue; Ezekiel J. Emanuel

A better understanding of the consequences of being turned down for living kidney donation could help transplant professionals to counsel individuals considering donation.


American Journal of Kidney Diseases | 2015

Functional Status, Time to Transplantation, and Survival Benefit of Kidney Transplantation Among Wait-Listed Candidates

Peter P. Reese; Justine Shults; Roy D. Bloom; Adam Mussell; Meera N. Harhay; Peter L. Abt; Matthew H. Levine; Kirsten L. Johansen; Jason T. Karlawish; Harold I. Feldman


American Journal of Kidney Diseases | 2017

Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial

Peter P. Reese; Roy D. Bloom; Jennifer Trofe-Clark; Adam Mussell; Daniel Leidy; Simona Levsky; Jingsan Zhu; Lin Yang; Wenli Wang; Andrea B. Troxel; Harold I. Feldman; Kevin G. Volpp


Journal of General Internal Medicine | 2016

Two Randomized Controlled Pilot Trials of Social Forces to Improve Statin Adherence among Patients with Diabetes

Peter P. Reese; Judd B. Kessler; Jalpa A. Doshi; Joelle Y. Friedman; Adam Mussell; Caroline Carney; Jingsan Zhu; Wenli Wang; Andrea B. Troxel; Peinie Young; Victor F. Lawnicki; Swapnil Rajpathak; Kevin G. Volpp


Transplantation | 2018

Race, Risk, and Willingness of End-stage Renal Disease Patients Without Hepatitis C (HCV) to Accept an HCV-infected Kidney Transplant

Maureen McCauley; Adam Mussell; David J. Goldberg; Deirdre Sawinski; Rodolfo N. Molina; Ricarda Tomlin; Sahil D. Doshi; Peter L. Abt; Roy D. Bloom; Emily A. Blumberg; Sanjay Kulkarni; Gabriela Esnaola; Justine Shults; Carrie Thiessen; Peter P. Reese

Collaboration


Dive into the Adam Mussell's collaboration.

Top Co-Authors

Avatar

Peter P. Reese

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Roy D. Bloom

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Harold I. Feldman

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Justine Shults

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Peter L. Abt

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Matthew H. Levine

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jason Karlawish

University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar

Jeffrey H. Silber

Children's Hospital of Philadelphia

View shared research outputs
Researchain Logo
Decentralizing Knowledge